Navigation Links
Sinovac Reports Unaudited Second Quarter Financial Results
Date:8/14/2014

BEIJING, Aug. 14, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and half year financial results for the period ended June 30, 2014.

Second Quarter 2014 Financial Highlights (compared to the second quarter 2013)

  • Quarterly sales were $12.1 million, a decrease of 30.7% from $17.5 million in the prior year period. Sales for the first six months were $25.6 million, a decrease of 6.8% YoY from $27.5 million.
  • Gross profit was $9.1 million, a decrease of 33.3% from $13.6 million in the prior year period.
  • Gross margin was 75.0%, compared to 77.9% in the prior year period.
  • Net loss attributable to common stockholders was $2.2 million, or $(0.04) per basic and diluted share, compared to net income attributable to common stockholders of $1.3 million, or $0.02 per basic and diluted share, in the second quarter of 2013.
  • Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, "While sales were impacted during the second quarter by short-term challenges from the external market environment, we are continuing to grow our sales channels and make strong progress in the development of our pipeline vaccines."

    "In July, we received the first tranche of our RMB 60 million government grant to build a dedicated facility for the production of the EV71 vaccine, which is currently under review by the Center for Drug Evaluation. During the second quarter, we received our clinical trial license for the pneumococcal polysaccharide vaccine (PPV) from the CFDA and expect to begin trials later this year."

    "Although we experienced decreased sales in the second quarter, we remain confident in our ability to execute our proven sales and marketing strategies, and continue to develop new vaccines that are both effective
    '/>"/>

    SOURCE Sinovac Biotech Ltd.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related biology technology :

    1. Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results
    2. Sinovac to Participate in UBS Asia Healthcare CEO Summit in November 2013
    3. Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility
    4. Sinovac to Present at 55th Annual BioPharma China Convention 2012 - Vaccine & Antibody Focus
    5. Sinovac Announces Resignation of Chup Hung Mok from Board of Directors
    6. Pressure BioSciences, Inc. Reports Second Quarter 2014 Financial Results and Provides Business Update
    7. RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2014
    8. Synthetic Biologics Reports Second Quarter 2014 Financial Results and Operational Highlights
    9. MarketResearch.com: New Biotechnology Market Research Reports Added to Kalorama Information Knowledge Center
    10. GenVec Reports Second Quarter 2014 Financial Results
    11. BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... September 19, 2014 Follow ... potential to revolutionize the world has attracted diverse ... and small start-ups. The early years of nanotechnology ... largely due to the high risks involved, which ... earmarked for this evolving technology have been growing ...
    (Date:9/19/2014)... BioTech News Coverage: Progress made ... of studies and trials.  Companies in focus are: GenSpera ... LLY ), Gilead Sciences Inc. (NASDAQ: ... and Arena Pharmaceuticals Inc. (NASDAQ: ARNA) GenSpera, ... for the treatment of cancer, announced that the United ...
    (Date:9/19/2014)... , September 19, 2014 The ... Spain , available today on PharmaBoardroom.com ... the Eurozone crisis that rocked the Spanish economy in 2009, ... Spanish pharma community has remained pragmatic in times of trouble. ... is still the fifth biggest European market, and the general ...
    (Date:9/18/2014)... 2014 A novel robotic system that ... is currently being tested as part of a biomedical ... Boston with the aim of determining if the robot, ... cancer biopsies faster, more accurate, less costly, and less ... the potential to deliver prostate cancer therapies with greater ...
    Breaking Biology Technology:Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7PharmaBoardroom Releases New Spain Pharmaceuticals Report 2PharmaBoardroom Releases New Spain Pharmaceuticals Report 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 2Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 4Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 5Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 6
    ... BioStorage Technologies, Inc.,(BST), announces the appointment of ... European operations in Griesheim, Germany. Hoffer,joins BST with ... fields of,clinical pharmacology and toxicology. In his new ... Chief Operating Officer for BST, and will,manage all ...
    ... Managed Care ... Facilities, ... ), a leading developer of,biosensor and microprocessor technologies for use in ... professional pulse oximeters; the PulseOx 6000(TM) and PulseOx,6100(TM)., At the ...
    ... declares spirit of hope and focus on mission, ... today,named Northwestern Medical Faculty Foundation as its expected ... proton therapy cancer treatment,and research center to be ... miles west of Chicago., The announcement came ...
    Cached Biology Technology:BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations 2SPO Medical Begins Shipping PulseOx 6000(TM) and PulseOx 6100(TM) 2SPO Medical Begins Shipping PulseOx 6000(TM) and PulseOx 6100(TM) 3NIU Seeks OK for New Proton Cancer Treatment and Research Center 2NIU Seeks OK for New Proton Cancer Treatment and Research Center 3
    (Date:9/18/2014)... -- Arizona turned its newborn screening program into a model ... earning it the first-ever Newborn Screening Quality Award from the ... Will Humble, M.P.H., Arizona,s Department of Health Services director, with ... established a policy of full transparency for the length of ... to the lab for analysis, and set a target of ...
    (Date:9/18/2014)... from several disciplines will be celebrated tonight at the ... in improving the health of premature infants and in ... The researchers, whose work was supported by the National ... former Atomic Energy Commission, will be honored at a ... A bipartisan group of Members of Congress will be ...
    (Date:9/18/2014)... Elsevier, a world-leading provider of scientific, technical and ... Research Management Society (ARMS), recognized the academic research ... Scopus Young Researcher of the Year Awards. , ... National Convention Centre and in conjunction with the ... representing Australia,s and New Zealand,s scientific community. Guest ...
    Breaking Biology News(10 mins):March of Dimes honors Arizona with first-ever newborn screening award 2March of Dimes honors Arizona with first-ever newborn screening award 33rd annual Golden Goose award ceremony honors 8 researchers; Unusual work had big results 2Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2
    ... and thrust," humans try to bank money to obtain financial ... gains. Many humans also end up in poverty traps, where ... living they find themselves unable to raise their heads above ... period, Gregory Rasmussen, currently at Lady Margaret Hall Oxford, intensively ...
    ... 1980s when they stumbled on small sugar molecules lurking in ... to be there, but they certainly weren,t supposed to be ... on and off. The conventional wisdom was that the ... determining their actions -- fell to phosphates, in a ...
    ... Laboratories engineer, and Bruce Osborn, chief operating officer of ... Mechanics magazine Breakthrough Innovator Award Oct. 15 during a ... Sponsored by Bristol-Myers Squibb, the Breakthrough Awards celebrate ... behind them. The joint Sandia/SES award is among 21 ...
    Cached Biology News:Running on rocket fuel 2Johns Hopkins researchers detect sweet cacophony while listening to cellular cross-talk 2Sandia, SES win Popular Mechanics Breakthrough Innovator Award 2